2020 Warren RFA Announcement
Notre Dame’s WFCDD grant supports collaborative, multidisciplinary drug discovery research with access to advanced facilities for chemical synthesis, screening, and computational drug design for a range of human diseases.
Funder: University of Notre Dame
Due Dates (Anticipated): November 2026 (application) | January 2027 (full application)
Funding Amounts: Up to ~$25,000 per award; typically funds up to 3 projects per cycle; 1-year duration.
Summary: Supports multidisciplinary drug discovery research at Notre Dame, offering resources for small molecule development, screening, and computational analysis.
Key Information: This is a forecasted opportunity; all dates are projected and subject to change.
Description
The Warren Family Center for Drug Discovery & Development (WFCDD) at the University of Notre Dame provides funding and core facility support for researchers engaged in drug discovery and development. The program is designed to foster multidisciplinary and collaborative research focused on the development of molecular probes, drugs, chemical tools, biological screens, and metabolomic assessments relevant to neurological disorders, infectious diseases, cancer, rare diseases, and other human health conditions. The Center offers access to advanced facilities for chemical synthesis, biological screening, assay development, and computational drug design, supporting both new and existing collaborations.
